Cancer cell-selective killing polymer/copper combination
- 16 November 2015
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 4 (1) , 115-120
Abstract
Chemotherapy has been adopted for cancer treatment for decades. However, its efficacy and safety are frequently compromised by the multidrug-resistance of cancer cells and the poor cancer cell selectivity of anticancer drugs. Hereby, we report a combination of a pyridine-2-thiol containing polymer and copper which can effectively kill a wide spectrum of cancer cells, including drug resistant cancer cells, while sparing normal cells. The polymer nanoparticle enters cells via an exofacial thiol facilitated route, and releases active pyridine-2-thiol with the help of intracellularly elevated glutathione (GSH). Due to their high GSH level, cancer cells are more vulnerable to the polymer/copper combination. In addition, RNA microarray analysis revealed that the treatment can reverse cancer cells’ upregulated oncogenes (CIRBP and STMN1) and downregulated tumor suppressor genes (CDKN1C and GADD45B) to further enhance the selectivity for cancer cells.Keywords
Funding Information
- National Institutes of Health (1R15CA188847-01A1, 5P20GM109091-02)
This publication has 34 references indexed in Scilit:
- RETRACTED ARTICLE: STMN-1 is a potential marker of lymph node metastasis in distal esophageal adenocarcinomas and silencing its expression can reverse malignant phenotype of tumor cellsBMC Cancer, 2014
- Controlling Cellular Uptake of Nanoparticles with pH-Sensitive PolymersScientific Reports, 2013
- Glutathione levels in human tumorsBiomarkers, 2012
- The proliferation rate paradox in antimitotic chemotherapyMolecular Biology of the Cell, 2012
- Circumventing Tumor Resistance to Chemotherapy by Nanotechnology2009
- Gene delivery through the use of a hyaluronate-associated intracellularly degradable crosslinked polyethyleneimineBiomaterials, 2009
- The anti-cancer drug, phenoxodiol, kills primary myeloid and lymphoid leukemic blasts and rapidly proliferating T cellsHaematologica, 2009
- Elevated copper and oxidative stress in cancer cells as a target for cancer treatmentCancer Treatment Reviews, 2009
- Enhanced Intracellular Delivery of the Reactive Oxygen Species (ROS)-Generating Copper Chelator D-Penicillamine via a Novel Gelatin−D-Penicillamine ConjugateBioconjugate Chemistry, 2008
- Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastomaNeuro-Oncology, 2005